Coronavirus: Experimental Covid-19 drug remdesivir is effective in monkeys, study says | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
February 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, FEBRUARY 02, 2023
Experimental Covid-19 drug remdesivir is effective in monkeys, study says

Coronavirus chronicle

TBS Report
18 April, 2020, 01:05 pm
Last modified: 18 April, 2020, 03:47 pm

Related News

  • Covid remains a public health emergency, says WHO
  • Thriving monkeys of Old Dhaka
  • Potential China wave is 'wild card' for ending Covid emergency: WHO advisors
  • WHO chief hopes Covid will no longer be emergency next year
  • The Prof Writes: Covid-19 - The one that got away from us

Experimental Covid-19 drug remdesivir is effective in monkeys, study says

The amount of virus found in the lungs was significantly lower in the treated group compared to the untreated group. The treated group also had less lung damage

TBS Report
18 April, 2020, 01:05 pm
Last modified: 18 April, 2020, 03:47 pm
Experimental Covid-19 drug remdesivir is effective in monkeys, study says

The experimental antiviral drug remdesivir has proven effective against Covid-19 in a small experiment involving monkeys, according to US government scientists.

The study initially was designed to follow dosing and treatment procedures used for hospitalized Covid-19 patients in a large human trial, reported Al Arabiya.

It involved two groups of six rhesus macaques that were deliberately infected with SARS-CoV-2. One group received the drug, which was developed by Gilead Sciences, and the other group did not. The group receiving the drug got their first intravenous dose 12 hours after infection then every day subsequently for six days.

The study is preliminary and has not yet been peer reviewed.The scientists timed the initial treatment to occur shortly before the virus reached its highest levels in the animals' lungs.

The treated animals showed significant improvement 12 hours after their first dose, a trend that continued over the week-long study.

One of the six treated animals showed mild breathing difficulty, while all six of the untreated monkeys had rapid and difficult breathing. The amount of virus found in the lungs was significantly lower in the treated group compared to the untreated group. The treated group also had less lung damage.

Remdesivir was among the first drugs mooted as a treatment for the novel coronavirus and its randomized clinical trials are at an advanced stage.

The health news website Stat on Thursday reported the drug had shown great efficacy at a Chicago hospital where patients who are part of those trials are being treated.

Remdesivir causes the virus to add mutations that can destroy it.

Top News

Coronavirus / monkey

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Song of the farmers as boro begins
    Song of the farmers as boro begins
  • Country's external position improves as trade deficit narrows by 21% in H1 FY23
    Country's external position improves as trade deficit narrows by 21% in H1 FY23
  • Infograph: TBS
    Remittance inflow increases 15% in January

MOST VIEWED

  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs
  • Photo: Collected
    India launches world’s 1st intranasal Covid vaccine
  • A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier
    US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot

Related News

  • Covid remains a public health emergency, says WHO
  • Thriving monkeys of Old Dhaka
  • Potential China wave is 'wild card' for ending Covid emergency: WHO advisors
  • WHO chief hopes Covid will no longer be emergency next year
  • The Prof Writes: Covid-19 - The one that got away from us

Features

An elderly couple's lonely battle to save Dhaka's trees

An elderly couple's lonely battle to save Dhaka's trees

20h | Panorama
Infographic: TBS

How to redirect inward remittances to formal channels

22h | Panorama
Photo: Bloomberg

How the 'madoffs of Manhattan' can unravel Gautam Adani's empire

21h | Panorama
Photo: Collected

Tips to incorporate sustainable construction

1d | Habitat

More Videos from TBS

Is Hathurusingha the most successful coach of Bangladesh?

Is Hathurusingha the most successful coach of Bangladesh?

11h | TBS SPORTS
Semiconductor, pharma should get more attention

Semiconductor, pharma should get more attention

13h | TBS Round Table
Dhali Al Mamun’s art depicts colonial impact

Dhali Al Mamun’s art depicts colonial impact

12h | TBS Stories
Jewel's humanitarian store

Jewel's humanitarian store

10h | TBS Stories

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Photo: Collected
Energy

8 Ctg power plants out of production

3
Photo: Saqlain Rizve
Bangladesh

Bangladeshi university students identified as problematic users of Facebook, internet: Study

4
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

5
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

6
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]